跳至主要内容
临床试验/NCT04653181
NCT04653181招募中不适用

Preoperative i.v. Iron Substitution in Patients With Colon Carcinoma and Iron-deficiency Anemia

Helsinki University Central Hospital1 个研究点 分布在 1 个国家目标入组 514 人开始时间: 2020年10月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
招募中
入组人数
514
试验地点
1
主要终点
postoperative complications

研究概览

简要总结

About 70% of colon cancer patients are anemic. Preoperative anemia in patients with colorectal cancer is associated with both impaired disease-free survival and overall survival. The purpose of this study is to compare the effects of preoperative iv iron substitution on postoperative recovery in preoperatively anemic (male Hb <130, female Hb <120) and iron deficient colon cancer patients in a prospective setup. As a primary outcome, the effect of iv-iron substitution on postoperative complications is investigated.

详细描述

Randomized preoperative iron substitution for patient with iron deficient anemia

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 100 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age> 18 years
  • Dg: Colon ca
  • The planned measure: the colon resection
  • Men: Hb <130, women: Hb <120 and iron deficiency (elevated TfR, low TrFesat or low ferritin)

排除标准

  • hyperreactivity for Ferinject
  • haemochromatosis
  • refusal for participation

研究组 & 干预措施

Iron arm

Experimental

Half of patients get i.v. iron preoperatively

干预措施: Ferric carboxymaltose (Drug)

结局指标

主要结局

postoperative complications

时间窗: 30 days

At study, difference between arms will be evaluated: Complications are analysed using Clavien-Dindo classification https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1360123/bin/3TT1.jpg

次要结局

  • Need for red blood cell transfusion(30 days)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Selja Koskensalo

Consultant, abdominal surgeon,Md, PhD

Helsinki University Central Hospital

研究点 (1)

Loading locations...

相似试验